Dosing initiates in phase I study of CORVax12, a unique DNA vaccine candidate against COVID-19 Jan. 28, 2021
Termination of Kuwait study of Avigan in hospitalized patients with moderate to severe COVID-19 Jan. 28, 2021
RSS